Cleared Traditional

K830029 - SIRECUST 400

K830029 is the FDA 510(k) clearance for SIRECUST 400 by Analogic Corp.. It is a Class 2 Cardiovascular device (product code DSI) cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K830029 · Analogic Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1983
Decision
86d
Days
Class 2
Risk

K830029 is an FDA 510(k) clearance for the SIRECUST 400. Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Analogic Corp. (Mchenry, US). The FDA issued a Cleared decision on March 31, 1983 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Analogic Corp. devices

Submission Details

510(k) Number K830029 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 04, 1983
Decision Date March 31, 1983
Days to Decision 86 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 125d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 228
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K830029.
AMBULATORY MONITORING DEVICE
K833162 · Oxford Medilog, Inc. · Jan 1984
ARRHYTHMIA III CARDULE #1919
K832693 · Spacelabs, Inc. · Nov 1983
WLECTROCARDIOGRAPH ECG-7204
K831274 · Nihon Kohden America, Inc. · Oct 1983
HEARTRATE PLUS ECG CARDULE #1918
K830306 · Spacelabs, Inc. · Mar 1983
SERIES 7000 BEDSIDE PATIENT MONITOR
K822718 · Marquette Electronics, Inc. · Oct 1982
MULTIPLE LEAD ARRHYTHMIA MODULE
K822030 · Marquette Electronics, Inc. · Sep 1982